Neuropathology tumours: Difference between revisions
Jump to navigation
Jump to search
Jensflorian (talk | contribs) →IHC: Update |
Jensflorian (talk | contribs) →By IHC: Update |
||
| Line 185: | Line 185: | ||
*[[CD20]] in PCNSL. | *[[CD20]] in PCNSL. | ||
*Cytokeratins in Carcinoma brain metastases, Plexus choroid tumours, [[AT/RT]], [[Papillary tumour of the pineal region]], [[Craniopharyngioma]]. | *Cytokeratins in Carcinoma brain metastases, Plexus choroid tumours, [[AT/RT]], [[Papillary tumour of the pineal region]], [[Craniopharyngioma]]. | ||
*[[EMA]] in [[Meningioma]] and carcinoma brain metastases. | |||
*PrgR in [[Meningioma]] and carcinoma metastases. | |||
*[[Synaptophysin]] in glioneuronal tumours and Pituitary adenoma and embryonal tumours. | |||
===Common neuropathology tumours in a table=== | ===Common neuropathology tumours in a table=== | ||